Literature DB >> 23825195

Differential T- and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2 years after preschool acellular booster vaccination.

Rose-Minke Schure1, Lotte H Hendrikx, Lia G H de Rond, Kemal Oztürk, Elisabeth A M Sanders, Guy A M Berbers, Anne-Marie Buisman.   

Abstract

This study investigated long-term cellular and humoral immunity against pertussis after booster vaccination of 4-year-old children who had been vaccinated at 2, 3, 4, and 11 months of age with either whole-cell pertussis (wP) or acellular pertussis (aP) vaccine. Immune responses were evaluated until 2 years after the preschool booster aP vaccination. In a cross-sectional study (registered trial no. ISRCTN65428640), blood samples were taken from wP- and aP-primed children prebooster and 1 month and 2 years postbooster. Pertussis vaccine antigen-specific IgG levels, antibody avidities, and IgG subclasses, as well as T-cell cytokine levels, were measured by fluorescent bead-based multiplex immunoassays. The numbers of pertussis-specific memory B cells and gamma interferon (IFN-γ)-producing T cells were quantified by enzyme-linked immunosorbent spot assays. Even 2 years after booster vaccination, memory B cells were still present and higher levels of pertussis-specific antibodies than prebooster were found in aP-primed children and, to a lesser degree, also in wP-primed children. The antibodies consisted mainly of the IgG1 subclass but also showed an increased IgG4 portion, primarily in the aP-primed children. The antibody avidity indices for pertussis toxin and pertactin in aP-primed children were already high prebooster and remained stable at 2 years, whereas those in wP-primed children increased. All measured prebooster T-cell responses in aP-primed children were already high and remained at similar levels or even decreased during the 2 years after booster vaccination, whereas those in wP-primed children increased. Since the Dutch wP vaccine has been replaced by aP vaccines, the induction of B-cell and T-cell memory immune responses has been enhanced, but antibody levels still wane after five aP vaccinations. Based on these long-term immune responses, the Dutch pertussis vaccination schedule can be optimized, and we discuss here several options.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23825195      PMCID: PMC3889587          DOI: 10.1128/CVI.00270-13

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  41 in total

1.  Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis.

Authors:  J Taranger; B Trollfors; T Lagergård; V Sundh; D A Bryla; R Schneerson; J B Robbins
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

Review 2.  Immunity to Bordetella pertussis.

Authors:  K H Mills
Journal:  Microbes Infect       Date:  2001-07       Impact factor: 2.700

3.  Analogous IgG subclass response to pertussis toxin in vaccinated children, healthy or affected by whooping cough.

Authors:  A Giammanco; S Taormina; A Chiarini; G Dardanoni; P Stefanelli; S Salmaso; P Mastrantonio
Journal:  Vaccine       Date:  2003-05-16       Impact factor: 3.641

4.  Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine.

Authors:  C M Ausiello; R Lande; F Urbani; B Di Carlo; P Stefanelli; S Salmaso; P Mastrantonio; A Cassone
Journal:  J Infect Dis       Date:  2000-06-05       Impact factor: 5.226

5.  CD4+ and CD8+ cells in cryopreserved human PBMC maintain full functionality in cytokine ELISPOT assays.

Authors:  Christian R Kreher; Markus T Dittrich; Robert Guerkov; Bernhard O Boehm; Magdalena Tary-Lehmann
Journal:  J Immunol Methods       Date:  2003-07       Impact factor: 2.303

6.  Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology.

Authors:  S S Long; C J Welkon; J L Clark
Journal:  J Infect Dis       Date:  1990-03       Impact factor: 5.226

Review 7.  Mechanism and regulation of immunoglobulin isotype switching.

Authors:  R L Coffman; D A Lebman; P Rothman
Journal:  Adv Immunol       Date:  1993       Impact factor: 3.543

8.  Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis.

Authors:  J Isacson; B Trollfors; J Taranger; T Lagergård
Journal:  Pediatr Infect Dis J       Date:  1995-06       Impact factor: 2.129

9.  A novel method for evaluating natural and vaccine induced serological responses to Bordetella pertussis antigens.

Authors:  G A M Berbers; M S E van de Wetering; P G M van Gageldonk; J F P Schellekens; F G A Versteegh; P F M Teunis
Journal:  Vaccine       Date:  2013-06-03       Impact factor: 3.641

10.  Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production.

Authors:  M Leef; K L Elkins; J Barbic; R D Shahin
Journal:  J Exp Med       Date:  2000-06-05       Impact factor: 14.307

View more
  28 in total

Review 1.  Waning and aging of cellular immunity to Bordetella pertussis.

Authors:  Inonge van Twillert; Wanda G H Han; Cécile A C M van Els
Journal:  Pathog Dis       Date:  2015-09-13       Impact factor: 3.166

Review 2.  Strategies and new developments to control pertussis, an actual health problem.

Authors:  María Emilia Gaillard; Daniela Bottero; Griselda Moreno; Martin Rumbo; Daniela Hozbor
Journal:  Pathog Dis       Date:  2015-08-09       Impact factor: 3.166

Review 3.  Prevention of pertussis: An unresolved problem.

Authors:  Susanna Esposito; Nicola Principi
Journal:  Hum Vaccin Immunother       Date:  2018-07-24       Impact factor: 3.452

4.  Waning Immunity and Microbial Vaccines-Workshop of the National Institute of Allergy and Infectious Diseases.

Authors:  Xin-Xing Gu; Stanley A Plotkin; Kathryn M Edwards; Alessandro Sette; Kingston H G Mills; Ofer Levy; Andrea J Sant; Annie Mo; William Alexander; Kristina T Lu; Christopher E Taylor
Journal:  Clin Vaccine Immunol       Date:  2017-07-05

Review 5.  What Is Wrong with Pertussis Vaccine Immunity? Why Immunological Memory to Pertussis Is Failing.

Authors:  Dimitri A Diavatopoulos; Kathryn Margaret Edwards
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-12-01       Impact factor: 10.005

Review 6.  Immune persistence after pertussis vaccination.

Authors:  Zhiyun Chen; Qiushui He
Journal:  Hum Vaccin Immunother       Date:  2017-01-03       Impact factor: 3.452

7.  Th1/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters.

Authors:  Ricardo da Silva Antunes; Mariana Babor; Chelsea Carpenter; Natalie Khalil; Mario Cortese; Alexander J Mentzer; Grégory Seumois; Christopher D Petro; Lisa A Purcell; Pandurangan Vijayanand; Shane Crotty; Bali Pulendran; Bjoern Peters; Alessandro Sette
Journal:  J Clin Invest       Date:  2018-08-06       Impact factor: 14.808

8.  Immune responses to pertussis antigens in infants and toddlers after immunization with multicomponent acellular pertussis vaccine.

Authors:  Olajumoke O Fadugba; Li Wang; Qingxia Chen; Natasha B Halasa
Journal:  Clin Vaccine Immunol       Date:  2014-09-24

9.  Polymorphism of IL-10 gene promoter region: association with T cell proliferative responses after acellular pertussis vaccination in adults.

Authors:  Kirsi Gröndahl-Yli-Hannuksela; Tero Vahlberg; Jorma Ilonen; Jussi Mertsola; Qiushui He
Journal:  Immunogenetics       Date:  2016-06-10       Impact factor: 2.846

10.  Identification of pertussis-specific effector memory T cells in preschool children.

Authors:  Lia de Rond; Rose-Minke Schure; Kemal Öztürk; Guy Berbers; Elisabeth Sanders; Inonge van Twillert; Maria Carollo; Françoise Mascart; Clara M Ausiello; Cecile A C M van Els; Kaat Smits; Anne-Marie Buisman
Journal:  Clin Vaccine Immunol       Date:  2015-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.